HTG Molecular Diagnostics Reports Second Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
HTG Molecular Diagnostics (HTGM) Tops Q2 EPS by 11c
August 11, 2022 4:52 PM EDTHTG Molecular Diagnostics (NASDAQ: HTGM) reported Q2 EPS of ($0.54), $0.11 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $1.49 million versus the consensus estimate of $2.35 million.
For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.
... More